Skip to main content

Kraft Robert O.'s Form 4 filing

Medpace Holdings, Inc. (MEDP) · filed Aug 26, 2024

Accession no.
0001668397-24-000155
Filed
Aug 26, 2024
Trade date
Aug 22-23, 2024
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $3.18M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Kraft Robert O.CIK 0001558592Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 22, 2024Common StockMOption exerciseAcquired+4,353$42.62+$185,524.864,873Direct
Aug 22, 2024Common StockSSaleDisposed−4,353$390.73F2−$1,700,847.69520Direct
Aug 23, 2024Common StockMOption exerciseAcquired+3,774$42.62+$160,847.884,294Direct
Aug 23, 2024Common StockSSaleDisposed−3,774$390.73F3−$1,474,615.02520Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 22, 2024Common StockMOption exerciseDisposed−4,353$0.00$03,774Direct
Aug 23, 2024Common StockMOption exerciseDisposed−3,774$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $390.00 to $392.055. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

Referenced by the price of 1 transaction in Table I.

F3

The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $390.00 to $392.01. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)